<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03318380</url>
  </required_header>
  <id_info>
    <org_study_id>17F.310</org_study_id>
    <nct_id>NCT03318380</nct_id>
  </id_info>
  <brief_title>Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis</brief_title>
  <official_title>Contrast-Enhanced Ultrasound Evaluation of Focal Liver Lesions in Patients With Cirrhosis or Other Risk Factors for Developing HCC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Cancer Center at Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bracco Diagnostics, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing&#xD;
      liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced&#xD;
      ultrasound imaging, may help find and diagnose liver cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To evaluate the sensitivity, specificity, positive and negative predictive values of&#xD;
      contrast-enhanced ultrasound (CEUS) for diagnosis of hepatocellular carcinoma (HCC) in&#xD;
      patients at risk for HCC in a multicenter setting.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To validate CEUS Liver Imaging Reporting and Data System (LI-RADS) and determine the&#xD;
      prevalence of HCC in each CEUS LI-RADS category.&#xD;
&#xD;
      II. To evaluate inter-reader reliability of CEUS for HCC diagnosis. III. To evaluate&#xD;
      covariates that might limit diagnostic performance of CEUS for HCC diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 19, 2018</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Actual">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of contrast-enhanced ultrasound evaluation (CEUS) for diagnosis of Hepatocellular cancer using a 95% confidence interval 95% confidence interval for HCC diagnosis using CEUS LR-5 classification</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>A value of 67% for sensitivity is expected based on recent meta-analysis studies of CEUS for focal liver mass characterization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of contrast-enhanced ultrasound evaluation (CEUS) for diagnosis of Hepatocellular cancer using a 95% confidence interval</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>A value of 91% for specificity is expected based on recent meta-analysis studies of CEUS for focal liver mass characterization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Predictive Value of contrast-enhanced ultrasound evaluation (CEUS) for diagnosis of Hepatocellular cancer using a 95% confidence interval</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>A value of 93% for Positive Predicative Value is expected based on recent meta-analysis studies of CEUS for focal liver mass characterization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative Predictive Value of contrast-enhanced ultrasound evaluation (CEUS) for diagnosis of Hepatocellular cancer using a 95% confidence interval</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>A value of 60% for Negative predictive value is expected based on recent meta-analysis studies of CEUS for focal liver mass characterization.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">612</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Diagnostic Contrast-Enhanced Ultrasound Imaging (CEUS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive sulfur hexafluoride IV and undergo CEUS imaging over 10 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dynamic Contrast-Enhanced Ultrasound Imaging</intervention_name>
    <description>Undergo CEUS</description>
    <arm_group_label>Diagnostic Contrast-Enhanced Ultrasound Imaging (CEUS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Capable of making informed decisions regarding his/her treatment&#xD;
&#xD;
          -  Have known cirrhosis or other risk factors for HCC, based on American Association for&#xD;
             the Study of Liver Diseases (AASLD) and European Association for the Study of the&#xD;
             Liver (EASL) guidelines (applicable in each site jurisdictions)&#xD;
&#xD;
          -  Patients with untreated focal liver observations on liver ultrasound or multiphase&#xD;
             contrast-enhanced CT or MRI performed as part of clinical standard of care within 4&#xD;
             weeks before patient enrollment.&#xD;
&#xD;
        OR&#xD;
&#xD;
        â€¢ Patients with untreated focal liver observations scheduled for follow-up multiphase&#xD;
        contrast-enhanced CT or MRI, biopsy or surgical excision as part of clinical standard of&#xD;
        care. CEUS should be performed within 4 weeks before or after follow-up imaging or within 4&#xD;
        weeks before biopsy or surgical excision.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are pregnant or lactating&#xD;
&#xD;
          -  Patients with focal liver observations less than 5 mm or greater than 5 cm in size&#xD;
&#xD;
          -  Patients with contraindications to CEUS&#xD;
&#xD;
          -  Patients with contraindications to both CT and MRI&#xD;
&#xD;
          -  Patients who are medically unstable, terminally ill, or whose clinical course is&#xD;
             unpredictable&#xD;
&#xD;
          -  Liver nodule previously treated with trans-arterial or thermal ablation&#xD;
&#xD;
          -  Patients who have received an investigational drug in the 30 days before CEUS, or will&#xD;
             receive one within 72 hour after their CEUS exam&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrej Lyshchik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sidney Kimmel Cancer Center at Thomas Jefferson University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sidney Kimmel Cancer Center at Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Paris</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.kimmelcancercenter.org/cancer-center.html</url>
    <description>Sidney Kimmel Cancer Center</description>
  </link>
  <link>
    <url>http://hospitals.jefferson.edu/</url>
    <description>Thomas Jefferson University Hospital</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

